Back

When not to start oral anticoagulation in CHA2DS2-VASc 1 - patients.

3 April 2022 (14:05 - 14:15)
Organised by:
Congress Presentation Part of: Two viewpoints on shared decision making in atrial fibrillation (AF) in practice Clinical EHRA Premium Access EHRA 2022

About the speaker

Photo
Professor Laurent Fauchier

University Hospital of Tours, Tours (France)

5 More presentations in this session

Presentation thumbnail
When not to institute oral anticoagulation in CHA2DS2-VASc 1 - professional perspective.
Professor H. Crijns (Maastricht, NL)
Slides Video
Presentation thumbnail
Debate: two viewpoints on shared decision-making in AF in practice - discussion.
Video
Presentation thumbnail
Shared decision-making in a persistent AF patient - professional perspective.
Professor G. Lip (Liverpool, GB)
Slides Video
Presentation thumbnail
Shared decision-making in a persistent AF patient - patient perspective.
Miss I. Drossart (Berlin, DE)
Slides Video
Presentation thumbnail
Debate: two viewpoints on shared decision-making in AF in practice - discussion.
Video

Access the full session

Session thumbnail
Two viewpoints on shared decision making in atrial fibrillation (AF) in practice
Video

The Event

Event poster

EHRA 2022

3 April 2022 14:05 CET
You may be interested in
thumbnail
Congress Session
Toward better risk stratification for stroke prevention in atrial fibrillation
27 August 2022
thumbnail
Congress Presentation
Device-detected atrial fibrillation: does thromboembolic risk affect decision-making on anticoagulation management?
31 March 2025
thumbnail
Congress Presentation
Hurdles in oral anticoagulation: case presentation
1 September 2024
thumbnail
Congress Presentation
Reducing stroke risk in patients with atrial high-rate episodes (AHRE)
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources